Montreal Manufacturing Technology Show
3 Nevers of Control Limits, Part 3
Never say “never”? I guess I overlooked that memo. In case you missed it, the last two columns were written about what you should never do with control limits. These three nevers, if avoided, will ensure that your control charts are useful, reliable tools.
Zimmer Recalls Patient Care Product Lines
(Zimmer Holdings Inc.: Warsaw, Indiana) -- Zimmer Holdings Inc.
Senator Grassley Questions FDA Drug Safety
(Washington, D.C.) — Republican senator Chuck Grassley of Iowa has asked for an independent assessment of how the Food and Drug Administra
Compliance to Regulations, PAT Initiative Remain Top Market Drivers in European Market
(Research and Markets: Dublin, Ireland) – A Frost & Sullivan research service titled “Automation and Control Solutions in the European Pharmaceutical Market” provides an analysis of the various factors driving and restraining the market, revenue forecasts, geographic trends and competit
QPEC Annual Quality and Process Excellence Conference
(Pharmaceutical Technology Magazine: Iselin, New Jersey) – QPEC’s Annual Quality and Process Excellence Conference will be held from July 21-23 at
CRO Completes Multinational Training Program for Principal Investigators from China, Duke University
Essential Elements of Effective CAPA Systems
From the perspective of the U.S.